Company intelligence / Profile preview

Natrol

Chatsworth, California, United Statesnatrol.com ↗

Ownership: Private
Development stage: Commercial

Overview

Natrol’s products are widely available over-the-counter dietary supplements. The company leads the U.S. market in drug-free sleep aids such as melatonin and has a strong presence in other wellness categories including stress/mood support, brain health, immunity, and beauty. Their formulas are NSF-certified and cGMP-compliant; some have USP certification. No clinical trial results typical of pharmaceutical companies—efficacy data comes from published ingredient studies or general supplement research.

Therapeutic areas: PsychiatryDermatologyImmunologyNeurology
Modalities: Small moleculeBotanicalsProteinPeptides
Industry: Food & Nutrition

Drug pipeline

2 assets

melatonin

Commercial

Indications: Sleep disorders

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Natrol.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natrol.

Explore the full profile